Join the 200th Anniversary Celebration

Original Article

Molecular Diagnosis of Familial Adenomatous Polyposis

Steven M. Powell, Gloria M. Petersen, Anne J. Krush, Susan Booker, Jin Jen, Francis M. Giardiello, Stanley R. Hamilton, Bert Vogelstein, and Kenneth W. Kinzler

N Engl J Med 1993; 329:1982-1987December 30, 1993

Abstract

Background

Familial adenomatous polyposis is an inherited disease characterized by multiple colorectal tumors. The diagnosis has classically been based on the detection of multiple colorectal adenomas. The recent identification of germline mutations of the APC gene in patients with familial adenomatous polyposis makes presymptomatic molecular diagnosis possible, but the widespread distribution of the many mutations within this very large gene have heretofore made the search for such mutations impractical. We describe a novel approach that allows molecular genetic diagnosis in the majority of patients with the disease.

Methods

We screened 62 unrelated patients from the Johns Hopkins Familial Adenomatous Polyposis Registry for germline APC mutations. Primary screening was accomplished by analysis of protein synthesized in vitro from surrogate APC genes. In addition, the relative amount of transcript from each APC allele was determined with an allele-specific-expression assay.

Results

The protein assay revealed truncated protein in 51 of the 62 patients (82 percent). In 3 of the 11 remaining patients, the allele-specific-expression assay revealed significantly reduced expression of one allele of the APC gene. The use of these two assays in combination successfully identified germline APC mutations in 87 percent of the 62 patients.

Conclusions

The protein and allele-specific-expression assays provide a practical and sensitive method for molecular diagnosis of familial adenomatous polyposis. This approach will facilitate care, allowing routine testing of subjects at risk and genetic confirmation of spontaneous mutations.

Media in This Article

Figure 1Principles of the In Vitro Synthesized-Protein Assay (Panel A) and the Allele-Specific-Expression Assay (Panel B).
Figure 2Protein Assay for the Detection of Known Truncating APC Mutations.
Article

Familial adenomatous polyposis is a dominantly inherited syndrome characterized by the progressive development of hundreds of adenomatous colorectal polyps, some of which inevitably progress to cancer. Although the clinical manifestations of this syndrome and its variants (e.g., Gardner's syndrome and Turcot syndrome) have been known for many years,1 the diagnosis still relies largely on the detection of numerous colorectal polyps during the second or third decade of life. Today, with familial adenomatous polyposis affecting nearly 1 in 8000 people2 and twice that many at risk, there are more than 50,000 people in the United States alone whose families could benefit from genetic testing.

The first step toward genetic testing was achieved when the inheritance of familial adenomatous polyposis was linked to a small region of chromosome 5 (5q21)3-5. This observation set the groundwork for linkage studies with nearby polymorphic DNA markers. Although linkage analysis is useful in some situations, it can benefit only a minority of kindreds with familial adenomatous polyposis6-8. Direct genetic testing became feasible when the APC gene on chromosome 5q21 was found to be mutated in the germline of patients with the syndrome9-12. The APC gene is also mutated frequently and early during sporadic colorectal tumorigenesis12-14.

Analyses of the entire coding region of the APC gene have detected mutations in 30 to 60 percent of patients with familial adenomatous polyposis, depending on the screening method used15-17. These analyses were complicated by the varied nature of the mutations, which were distributed over a large portion of the APC gene, which encompasses more than 8500 base pairs (bp) of open reading frame. Moreover, these mutations were mostly changes in single base pairs, small insertions, or small deletions.

Consequently, we sought to devise a rapid and sensitive method for the detection of APC gene mutations. Because the majority of mutations in patients with familial adenomatous polyposis result in truncations of the APC gene products due to frameshifts, nonsense mutations, and splice-site changes, we developed a method based on the examination of APC proteins synthesized in vitro and endogenous APC transcripts. The usefulness of this approach for the genetic diagnosis of familial adenomatous polyposis was then evaluated in 62 patients.

Methods

Study Group

We studied the most recent 62 unrelated patients (37 female and 25 male patients) enrolled in the Johns Hopkins Familial Adenomatous Polyposis Registry from whom blood samples could be obtained. The patients' mean age was 41 years (range, 16 to 67). Fourteen patients had spontaneous mutations. All 62 patients were confirmed to have classic adenomatous polyposis as defined by the presence of more than 100 colorectal polyps at the time of endoscopy, radiologic study, or examination of resected colons. The adenomatous nature of the polyps was documented by histopathological analysis.

We also studied nine unrelated normal subjects (one woman and eight men; mean age, 32 years; range, 20 to 43) and seven relatives (five women and two men; mean age, 56 years; range, 32 to 75) of the three patients with familial adenomatous polyposis in whom an alteration was detected on the allele-specific-expression assay. Affected relatives met the criteria for classic adenomatous polyposis described above. Informed consent in accord with institutional policy was obtained from each subject before collection of the blood samples.

Preparation of Templates

Blood samples from 45 of the 62 patients with familial adenomatous polyposis were collected in EDTA and stored overnight at ambient temperature. Genomic DNA was prepared by Chelex extraction of 30 microliters of whole blood as described previously18. RNA was isolated by the acid guanidium isothiocyanate-phenol-chloroform extraction method19 from peripheral-blood mononuclear cells prepared from 10 ml of whole blood by Ficoll-Hypaque (Histopaque-1077, Sigma Chemical, St. Louis) gradient centrifugation. Blood samples from the normal subjects and the patients' relatives were processed in a similar manner.

For the remaining 17 patients, lymphoblastoid cell lines were established by Epstein-Barr virus-induced immortalization of lymphocytes isolated from peripheral blood. RNA and DNA were extracted from these cells as described19,20.

In Vitro Synthesized-Protein Assay

For the purposes of analysis with the polymerase chain reaction (PCR), the APC gene was divided into five overlapping segments containing codons 1 to 804, 686 to 1217, 1099 to 1693, 1555 to 2256, and 2131 to 2843. The primers used for PCR amplification were designed to introduce a T7 promoter sequence for the initiation of transcription by T7 RNA polymerase, as well as a consensus sequence for the initiation of translation21. Segment 1 was isolated from complementary DNA templates prepared by reverse transcription of messenger RNA (mRNA). Segments 2 to 5 were isolated directly from genomic DNA.

PCR products were used directly (without purification) as templates in coupled transcription-translation reactions (Promega, Madison, Wis.) with 40 micro Ci of 35S-labeled methionine (ICN, Irvine, Calif.) and incubated for one hour at 30 degrees C. The samples were diluted in sample buffer, boiled for five minutes, and analyzed by electrophoresis on a sodium dodecyl sulfate-polyacrylamide gel with a gradient of 10 to 20 percent. The proteins were visualized by fluorography after the gel had been impregnated with ENHANCE (New England Nuclear, Boston).

Allele-Specific-Expression Assay

The two-site polymorphisms used in this assay were silent changes of a single base pair, one in exon 11 (codon 486) and one in exon 13 (codon 545)13. Informative heterozygous cases were first sought by analyzing amplified APC exons 11 and 13 from genomic DNA. The genomic PCR product was added to a modified allele-specific ligation assay22 (and Jen J, et al.: unpublished data). A common 9-bp 32P-labeled oligomer and two different-sized allele-specific oligomers (8 and 10 bp) were used in the ligation assay. Ligation products were separated by polyacrylamide-urea (8 M) sequencing gels, and the abundance of each allele was determined by the relative amount of allele-specific ligation product (19 bp for allele A and 17 bp for allele B). Quantitation was achieved with a PhosphorImager (Molecular Dynamics, Sunnyvale, Calif.). The PCR products of segment 1 (derived from mRNA, as for the protein assay) were then analyzed in the same quantitative ligation reaction to determine the relative abundance of APC transcripts expressed from each allele. The sequences of the PCR primers used in this study as well as a detailed protocol for PCR and the analysis of the PCR products are available from the National Auxiliary Publications Service(NAPS).

Results

The observation that mutations of the APC gene in patients with familial adenomatous polyposis almost always result in a truncated protein prompted us to develop an assay based on an examination of the APC gene product. This assay was made possible by two advances in molecular genetics. First, PCR allows the rapid isolation of specific gene segments from samples obtained from patients23. Second, the isolated gene segments can be used to produce proteins with in vitro transcription and translation reactions24. Truncating mutations can then easily be identified as small protein products after gel electrophoresis and autoradiography. A diagram of this procedure is shown in Figure 1AFigure 1Principles of the In Vitro Synthesized-Protein Assay (Panel A) and the Allele-Specific-Expression Assay (Panel B)..

To validate the in vitro synthesized protein assay, we first analyzed 20 sporadically occurring colorectal tumors that were shown by sequence analysis to have truncating APC mutations13. In each tumor, a specific truncated protein corresponding to the predicted size of the mutant product was identified (examples are shown in Figure 2Figure 2Protein Assay for the Detection of Known Truncating APC Mutations.). A full-length protein product of the remaining normal allele was also found in each tumor.

We next evaluated the efficacy of this approach for the molecular diagnosis of familial adenomatous polyposis from peripheral-blood samples. Analysis of the entire coding region of the APC gene with the protein assay identified truncating mutations in 51 patients (82 percent) (examples are shown in Figure 3Figure 3Protein Assay for the Detection of APC Mutations in Patients with Familial Adenomatous Polyposis.). Twelve of these mutations were from patients with spontaneous mutations (i.e., patients with first-generation mutations). The 51 mutations were distributed over the first four segments, with 29, 10, 11, and 1 in segments 1, 2, 3, and 4, respectively.

Since some patients with familial adenomatous polyposis may have promoter or splicing mutations that lead to reduced levels of normal APC transcripts, we also addressed ways to identify such mutations. Because such mutations, which influence the expression of a single allele, could result at most in a 50 percent decrease in the total amount of transcript, we devised an assay for the individual expression of each of the two alleles. We took advantage of polymorphisms affecting a single base pair to create an allele-specific-expression assay to detect this type of alteration (Figure 1B). The accuracy of this assay was demonstrated in an allele-mixing experiment. RNA from two patients, each homozygous for different alleles at the polymorphic site in exon 11, was mixed together in defined ratios, amplified, and analyzed by the allele-specific-expression assay. The relative amounts of each allele determined by the assay were similar to the predicted ratios (r = 0.997) (Figure 4Figure 4Allele-Mixing Analysis to Determine the Accuracy of the Allele-Specific-Expression Assay.).

We then used the assay to evaluate the 11 patients with familial adenomatous polyposis who had no detectable abnormalities in APC protein, as well as normal subjects. Seven patients and six normal subjects were heterozygous for at least one of the two polymorphisms. The relative allele ratio of the genomic DNA from these 13 subjects and of the RNA from the 6 normal subjects was 1.0 ±0.2 (mean ±SD). Three of the patients with familial adenomatous polyposis had a significant reduction in the expression of one allele (Figure 5Figure 5Detection of Altered APC Transcripts by the Allele-Specific-Expression Assay.). In each of these three patients, the ratio of allele abundance in the expressed RNA template was significantly different from that of the normal subjects and from that found with the use of genomic DNA instead of RNA as a template (P<0.001 by two-tailed unpaired Student's t-test). At least one other affected family member from the kindreds of these three patients was also studied and found to have a similar reduction in the expression of the same allele, demonstrating the expected inheritance. Used in combination, the protein assay and the allele-specific-expression assay successfully identified APC mutations in 87 percent of the 62 kindreds with familial adenomatous polyposis tested.

Discussion

We have described practical molecular genetic methods for identifying inactivating mutations in large genes that have several advantages over currently available genetic methods. Although useful, genetic-linkage analysis cannot be applied when kindreds are small, the requisite number of affected family members is not available, or polymorphic markers are uninformative. Furthermore, linkage analysis cannot be applied when a spontaneous mutation is suspected. Indeed, spontaneous mutations account for approximately one third of the cases of familial adenomatous polyposis,25 and they were present in 14 of the patients in this study, 12 of whom had identifiable APC mutations. In addition, because linkage analysis is indirect, some degree of uncertainty always remains. Several studies have described the direct detection of APC mutations in patients with familial adenomatous polyposis, with detection rates ranging from 10 to 60 percent, depending on the method used9,15-17,26-29; the methods were generally very labor intensive and could miss a substantial fraction of subtle changes in single base pairs. In many patients the entire APC gene was not examined, presumably because of practical considerations related to its large size. Western blot analysis has been used to detect truncated APC proteins, but many such proteins in familial adenomatous polyposis are unstable in vivo, precluding their demonstration by this technique30. For example, we could not identify truncated APC proteins in three of seven patients with familial adenomatous polyposis studied by Western blot analysis, but mutations in all seven were easily detectable with the in vitro synthesized-protein assay.

Analysis of proteins whose synthesis is directed by surrogate APC genes can rapidly identify mutations that result in truncated APC proteins, whether caused by splicing mutations, point mutations, or frameshifts. Likewise, the allele-specific-expression assay identified mutations as an imbalance in the representation of alleles at the RNA-transcript level. A variety of events, including promoter mutations, splicing mutations, mutations altering transcript stability, and even imprinting abnormalities, have the potential to be detected by the allele-specific-expression assay. These molecular approaches should be applicable to the identification of mutations that lead to shortened proteins or reduced expression in any gene, but should be especially useful in the analysis of large genes for which conventional analytical methods are too labor intensive. The mutations in the recently isolated genes responsible for neurofibromatosis type 231,32 and von Hippel-Lindau disease33 are predominantly of the type that would be detected by our assays.

The detection of APC gene alterations in 87 percent of patients with familial adenomatous polyposis illustrates the usefulness of this approach as a genetic test for the disease. Moreover, the ability to use the assay for prenatal diagnosis could be important to patients planning a family. In providing a test for presymptomatic testing, our assays should have practical benefits for kindreds with familial adenomatous polyposis. Registry records for the 54 patients in whom we detected APC gene abnormalities show that there are at least 280 relatives at risk for the disease who can now be tested. The 166 subjects who are under the age of 20 years should gain the most from this analysis. Subjects who have a positive test can at least be spared the anxiety associated with not knowing whether they have the disease. They can also benefit from improved management, because early diagnosis should ensure that appropriate preventive measures are taken well before the development of colorectal cancers. Finally, the importance of preclinical testing is heightened by recent studies showing promise in the pharmacologic treatment of polyposis34-38. Such treatment of subjects who have inherited a mutated APC gene should be more efficacious if initiated before polyps appear.

Supported in part by grants from the Clayton Fund, the Cancer Research Foundation of America, and the National Institutes of Health (CA-35494, CA-57345, and CA-44688). Dr. Vogelstein is an American Cancer Society Research Professor.

NAPS See NAPS document no. 05068 for seven pages of supplementary material. To order, contact NAPS c/o Microfiche Publications, 248 Hempstead Tpk., West Hempstead, NY 11552.

We are indebted to the patients, their families, and their physicians and to the Delaware Registry for Hereditary Colorectal Cancer for providing blood samples and kindred information through the Johns Hopkins Familial Adenomatous Polyposis Registry.

Source Information

From the Departments of Oncology (S.M.P., S.B., J.J., S.R.H., B.V., K.W.K.), Pathology (S.R.H.), and Medicine (A.J.K., F.M.G.), Johns Hopkins University School of Medicine, and the Department of Epidemiology, Johns Hopkins University School of Hygiene and Public Health (G.M.P.), both in Baltimore.

Address reprint requests to Dr. Kinzler at the Johns Hopkins Oncology Center, 424 N. Bond St., Baltimore, MD 21231-1001.

References

References

  1. 1

    Bussey HJR. Historical developments in familial adenomatous polyposis. In: Herrera L, ed. Familial adenomatous polyposis. New York: Alan R. Liss, 1990:1-7.

  2. 2

    Alm T, Licznerski G. The intestinal polyposes. Clin Gastroenterol 1973;2:577-602

  3. 3

    Herrera L, Kakati S, Gibas L, Pietrzak E, Sandberg AA. Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet 1986;25:473-476
    CrossRef | Web of Science | Medline

  4. 4

    Bodmer WF, Bailey CJ, Bodmer J, et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987;328:614-616
    CrossRef | Web of Science | Medline

  5. 5

    Leppert M, Dobbs M, Scambler P, et al. The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 1987;238:1411-1413
    CrossRef | Web of Science | Medline

  6. 6

    Petersen GM, Slack J, Nakamura Y. Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology 1991;100:1658-1664
    Web of Science | Medline

  7. 7

    Cachon-Gonzalez MB, Delhanty JD, Burn J, et al. Linkage analysis in adenomatous polyposis coli: the use of four closely linked DNA probes in 20 UK families. J Med Genet 1991;28:681-685
    CrossRef | Web of Science | Medline

  8. 8

    Spirio L, Nelson L, Ward K, Burt R, White R, Leppert M. A CA-repeat polymorphism close to the adenomatous polyposis coli (APC) gene offers improved diagnostic testing for familial APC. Am J Hum Genet 1993;52:286-296
    Web of Science | Medline

  9. 9

    Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600
    CrossRef | Web of Science | Medline

  10. 10

    Joslyn G, Carlson M, Thliveris A, et al. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 1991;66:601-613
    CrossRef | Web of Science | Medline

  11. 11

    Kinzler KW, Nilbert MC, Su L-K, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991;253:661-665
    CrossRef | Web of Science | Medline

  12. 12

    Nishisho I, Nakamura Y, Miyoshi Y, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991;253:665-669
    CrossRef | Web of Science | Medline

  13. 13

    Powell SM, Zilz N, Beazer-Barclay Y, et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992;359:235-237
    CrossRef | Web of Science | Medline

  14. 14

    Miyoshi Y, Nagase H, Ando H, et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1992;1:229-233
    CrossRef | Medline

  15. 15

    Miyoshi Y, Ando H, Nagase H, et al. Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci U S A 1992;89:4452-4456
    CrossRef | Web of Science | Medline

  16. 16

    Groden J, Gelbert L, Thliveris A, et al. Mutational analysis of patients with adenomatous polyposis: identical inactivating mutations in unrelated individuals. Am J Hum Genet 1993;52:263-272
    Web of Science | Medline

  17. 17

    Nagase H, Miyoshi Y, Horii A, et al. Screening for germ-line mutations in familial adenomatous polyposis patients: 61 new patients and a summary of 150 unrelated patients. Hum Mutat 1992;1:467-473
    CrossRef | Medline

  18. 18

    Walsh PS, Metzger DA, Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 1991;10:507-513

  19. 19

    Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159
    CrossRef | Web of Science | Medline

  20. 20

    Goelz SE, Hamilton SR, Vogelstein B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun 1985;130:118-126
    CrossRef | Web of Science | Medline

  21. 21

    Kozak M. An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 1987;15:8125-8148
    CrossRef | Web of Science | Medline

  22. 22

    Landegren U, Kaiser R, Sanders J, Hood L. A ligase-mediated gene detection technique. Science 1988;241:1077-1080
    CrossRef | Web of Science | Medline

  23. 23

    Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487-491
    CrossRef | Web of Science | Medline

  24. 24

    Sarkar G, Sommer SS. Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity. Science 1989;244:331-334
    CrossRef | Web of Science | Medline

  25. 25

    Bulow S. Clinical features in familial polyposis coli: results of the Danish Polyposis Register. Dis Colon Rectum 1986;29:102-107
    CrossRef | Web of Science | Medline

  26. 26

    Fodde R, van der Luijt R, Wijnen J, et al. Eight novel inactivating germ line mutations at the APC gene identified by denaturing gradient gel electrophoresis. Genomics 1992;13:1162-1168
    CrossRef | Web of Science | Medline

  27. 27

    Cottrell S, Bicknell D, Kaklamanis L, Bodmer WF. Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas. Lancet 1992;340:626-630
    CrossRef | Web of Science | Medline

  28. 28

    Olschwang S, Laurent-Puig P, Groden J, White R, Thomas G. Germ-line mutations in the first 14 exons of the adenomatous polyposis coli (APC) gene. Am J Hum Genet 1993;52:273-279
    Web of Science | Medline

  29. 29

    Varesco L, Gismondi V, James R, et al. Identification of APC gene mutations in Italian adenomatous polyposis coli patients by PCR-SSCP analysis. Am J Hum Genet 1993;52:280-285
    Web of Science | Medline

  30. 30

    Smith KJ, Johnson KA, Bryan TM, et al. The APC gene product in normal and tumor cells. Proc Natl Acad Sci U S A 1993;90:2846-2850
    CrossRef | Web of Science | Medline

  31. 31

    Trofatter JA, MacCollin MM, Rutter JL, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993;72:791-800
    CrossRef | Web of Science | Medline

  32. 32

    Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993;363:515-521
    CrossRef | Web of Science | Medline

  33. 33

    Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993;260:1317-1320
    CrossRef | Web of Science | Medline

  34. 34

    Waddell WR, Loughry RW. Sulindac for polyposis of the colon. J Surg Oncol 1983;24:83-87
    CrossRef | Web of Science | Medline

  35. 35

    Waddell WR, Ganser GF, Cerise EJ, Loughry RW. Sulindac for polyposis of the colon. Am J Surg 1989;157:175-179
    CrossRef | Web of Science | Medline

  36. 36

    Rigau J, Pique JM, Rubio E, Planas R, Tarrech JM, Bordas JM. Effects of long-term sulindac therapy on colonic polyposis. Ann Intern Med 1991;115:952-955
    Web of Science | Medline

  37. 37

    Labayle D, Fischer D, Vielh P, et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991;101:635-639
    Web of Science | Medline

  38. 38

    Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993;328:1313-1316
    Full Text | Web of Science | Medline

Citing Articles (210)

Citing Articles

  1. 1

    Maria Cristina Curia, Sabrina De Iure, Laura De Lellis, Serena Veschi, Sandra Mammarella, Marquitta J. White, Jacquelaine Bartlett, Angelo Di Iorio, Cristina Amatetti, Marco Lombardo, Patrizia Di Gregorio, Pasquale Battista, Renato Mariani–Costantini, Scott M. Williams, Alessandro Cama. (2011) Increased Variance in Germline Allele-Specific Expression of APC Associates With Colorectal Cancer. Gastroenterology
    CrossRef

  2. 2

    I. D'Errico, L. Salvatore, S. Murzilli, G. Lo Sasso, D. Latorre, N. Martelli, A. V. Egorova, R. Polishuck, K. Madeyski-Bengtson, C. Lelliott, A. J. Vidal-Puig, P. Seibel, G. Villani, A. Moschetta. (2011) Peroxisome proliferator-activated receptor-  coactivator 1-  (PGC1 ) is a metabolic regulator of intestinal epithelial cell fate. Proceedings of the National Academy of Sciences 108:16, 6603-6608
    CrossRef

  3. 3

    Kirsten F. L. Douma, Eveline M. A. Bleiker, Hans F. A. Vasen, Chad M. Gundy, Miranda A. Gerritsma, Neil K. Aaronson. (2011) Psychological distress and quality of life of partners of individuals with familial adenomatous polyposis. Psycho-Oncology 20:2, 146-154
    CrossRef

  4. 4

    Robert E. Petras. 2011. Gastrointestinal Pathology. , 699-716.
    CrossRef

  5. 5

    Theresa Tran, Andrew G Gianoukakis. (2010) Familial thyroid neoplasia: impact of technological advances on detection and monitoring. Current Opinion in Endocrinology, Diabetes and Obesity 17:5, 425-431
    CrossRef

  6. 6

    Cristina Albuquerque, Célia Baltazar, Bruno Filipe, Filipa Penha, Teresa Pereira, Ron Smits, Marília Cravo, Pedro Lage, Paulo Fidalgo, Isabel Claro, Paula Rodrigues, Isabel Veiga, José Silva Ramos, Isabel Fonseca, Carlos Nobre Leitão, Riccardo Fodde. (2010) Colorectal cancers show distinct mutation spectra in members of the canonical WNT signaling pathway according to their anatomical location and type of genetic instability. Genes, Chromosomes and Cancer 49:8, 746-759
    CrossRef

  7. 7

    Ester Castellsagué, Sara González, Elisabet Guinó, Kristen N. Stevens, Ester Borràs, Victoria M. Raymond, Conxi Lázaro, Ignacio Blanco, Stephen B. Gruber, Gabriel Capellá. (2010) Allele-Specific Expression of APC in Adenomatous Polyposis Families. Gastroenterology 139:2, 439-447.e1
    CrossRef

  8. 8

    Ignacio Alfaro, Teresa Ocaña, Antoni Castells, Carmen Cordero, Marta Ponce, Teresa Ramón Y Cajal, Montserrat Andreu, Luis Bujanda, Maite Herráiz, Antonio José Hervás Molina, Fernando Fernández-Bañares, Sabino Riestra-Menéndez, Carla Gargallo, Ana Ruiz, Marco Bustamante, Ignacio Blanco, Fernando Martínez de Juan. (2010) Características de los pacientes con poliposis adenomatosa familiar en España. Resultados iniciales del Registro Español de Poliposis Adenomatosa Familiar. Medicina Clínica 135:3, 103-108
    CrossRef

  9. 9

    H. Pinheiro, R. Bordeira-Carrico, S. Seixas, J. Carvalho, J. Senz, P. Oliveira, P. Inacio, L. Gusmao, J. Rocha, D. Huntsman, R. Seruca, C. Oliveira. (2010) Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer. Human Molecular Genetics 19:5, 943-952
    CrossRef

  10. 10

    Heather Hampel. (2009) Genetic Testing for Hereditary Colorectal Cancer. Surgical Oncology Clinics of North America 18:4, 687-703
    CrossRef

  11. 11

    Shab Mireskandari, Jennifer Sangster, Bettina Meiser, Belinda Thewes, Claire Groombridge, Allan Spigelman, Lesley Andrews. (2009) Psychosocial Impact of Familial Adenomatous Polyposis on Young Adults: A Qualitative Study. Journal of Genetic Counseling 18:5, 409-417
    CrossRef

  12. 12

    Andrzej Pławski, Marta Podralska, Wojciech Cichy, Michał Drews, Piotr Krokowicz, Ryszard Słomski. (2009) DNA Bank for Polish Patients with a Predisposition for Intestinal Polyposis. Polish Journal of Surgery 81:10, 465-473
    CrossRef

  13. 13

    Rod K Nibbe, Mark R Chance. (2009) Approaches to biomarkers in human colorectal cancer: looking back, to go forward. Biomarkers in Medicine 3:4, 385-396
    CrossRef

  14. 14

    Benoit Brasseur, Karin Dahan, Véronique Beauloye, Noella Blétard, Christophe Chantrain, Sophie Dupont, Jean-Luc Guarin, Christiane Vermylen, Bénédicte Brichard. (2009) Multiple Neoplasia in a 15-year-old Girl With Familial Adenomatous Polyposis. Journal of Pediatric Hematology/Oncology 31:7, 530-532
    CrossRef

  15. 15

    Susana Mão de Ferro, Alexandra Suspiro, Paulo Fidalgo, Pedro Lage, Paula Rodrigues, Sofia Fragoso, Inês Vitoriano, Célia Baltazar, Cristina Albuquerque, António Bettencourt, Carlos Nobre Leitão. (2009) Aggressive Phenotype of MYH-Associated Polyposis with Jejunal Cancer and Intra-Abdominal Desmoid Tumor. Diseases of the Colon & Rectum 52:4, 742-745
    CrossRef

  16. 16

    K. F. L. Douma, N. K. Aaronson, H. F. A. Vasen, E. M. A. Bleiker. (2008) Psychosocial issues in genetic testing for familial adenomatous polyposis: a review of the literature. Psycho-Oncology 17:8, 737-745
    CrossRef

  17. 17

    Yong-Sam Kim, Ok Lye Son, Ju Yeon Lee, Sun Hee Kim, Sejeong Oh, Yoon Suk Lee, Cheorl-Ho Kim, Jong Shin Yoo, Jeong-Hwa Lee, Eiji Miyoshi, Naoyuki Taniguchi, Samir M. Hanash, Hyang Sook Yoo, Jeong Heon Ko. (2008) Lectin precipitation using phytohemagglutinin-L 4 coupled to avidin-agarose for serological biomarker discovery in colorectal cancer. PROTEOMICS 8:16, 3229-3235
    CrossRef

  18. 18

    R Yanaru-Fujisawa, T Matsumoto, Y Ushijima, M Esaki, M Hirahashi, M Gushima, T Yao, Y Nakabeppu, M Iida. (2008) Genomic and functional analyses of MUTYH in Japanese patients with adenomatous polyposis. Clinical Genetics 73:6, 545-553
    CrossRef

  19. 19

    Brian Somoano, Hensin Tsao. (2008) Genodermatoses with Cutaneous Tumors and Internal Malignancies. Dermatologic Clinics 26:1, 69-87
    CrossRef

  20. 20

    Francesca Cattaneo, Sara Molatore, Markos Mihalatos, Angela Apessos, Tiziana Venesio, Silvia Bione, Pierangela Grignani, Georgios Nasioulas, Guglielmina Nadia Ranzani. (2007) Heterogeneous molecular mechanisms underlie attenuated familial adenomatous polyposis. Genetics in Medicine 9:12, 836-841
    CrossRef

  21. 21

    Stefan Aretz, Dietlinde Stienen, Nicolaus Friedrichs, Susanne Stemmler, Siegfried Uhlhaas, Nils Rahner, Peter Propping, Waltraut Friedl. (2007) Somatic APC mosaicism: a frequent cause of familial adenomatous polyposis (FAP). Human Mutation 28:10, 985-992
    CrossRef

  22. 22

    Maartje Nielsen, Elsa Bik, Frederik J Hes, Martijn H Breuning, Hans F A Vasen, Egbert Bakker, Carli M J Tops, Marjan M Weiss. (2007) Genotype–phenotype correlations in 19 Dutch cases with APC gene deletions and a literature review. European Journal of Human Genetics 15:10, 1034-1042
    CrossRef

  23. 23

    Clemens Neufert, Christoph Becker, Markus F Neurath. (2007) An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nature Protocols 2:8, 1998-2004
    CrossRef

  24. 24

    Jennifer D Holman, Jonathan A Dyer. (2007) Genodermatoses with malignant potential. Current Opinion in Pediatrics 19:4, 446-454
    CrossRef

  25. 25

    Takeyoshi Itsukuma, Hideki Ishikawa, Mahito Misawa, Shunro Kai, Yoshihiro Fujimori, Kazuhiko Nakagawa, Seiichi Hirota, Ayako Sugihara, Nobuyuki Terada, Hiroshi Hara. (2007) Familial adenomatous polyposis complicated by chronic myelogenous leukemia: response to imatinib mesylate. Journal of Gastroenterology 42:5, 402-405
    CrossRef

  26. 26

    M Nielsen, FJ Hes, FM Nagengast, MM Weiss, EM Mathus-Vliegen, H Morreau, MH Breuning, JT Wijnen, CMJ Tops, HFA Vasen. (2007) Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Clinical Genetics 71:5, 427-433
    CrossRef

  27. 27

    Lu Ping Tan, Ban Kim Ng, Pauline Balraj, Patricia Kim Chooi Lim, Suat Cheng Peh. (2007) No difference in the occurrence of mismatch repair defects and APC and CTNNB1 genes mutation in a multi-racial colorectal carcinoma patient cohort. Pathology 39:2, 228-234
    CrossRef

  28. 28

    Constanze Pagenstecher, Dorothea Gadzicki, Dietlinde Stienen, Siegfried Uhlhaas, Elisabeth Mangold, Nils Rahner, Mine Arslan-Kirchner, Peter Propping, Waltraut Friedl, Stefan Aretz. (2007) A Complex Rearrangement in the APC Gene Uncovered by Multiplex Ligation-Dependent Probe Amplification. The Journal of Molecular Diagnostics 9:1, 122-126
    CrossRef

  29. 29

    Rosa Valanzano, Ferdinando Ficari, Maria Cristina Curia, Gitana Aceto, Serena Veschi, Alessandro Cama, Pasquale Battista, Francesco Tonelli. (2007) Balance between endoscopic and genetic information in the choice of ileorectal anastomosis for familial adenomatous polyposis. Journal of Surgical Oncology 95:1, 28-33
    CrossRef

  30. 30

    Jennifer Scalia Wilbur, Adam A. Rojan, Robert D. Legare. 2007. The Genetics of Breast and Gynecologic Cancers. , 43-71.
    CrossRef

  31. 31

    Michael J. O??Brien, Shi Yang, Charline Mack, Huihong Xu, Christopher S. Huang, Elizabeth Mulcahy, Mark Amorosino, Francis A. Farraye. (2006) Comparison of Microsatellite Instability, CpG Island Methylation Phenotype, BRAF and KRAS Status in Serrated Polyps and Traditional Adenomas Indicates Separate Pathways to Distinct Colorectal Carcinoma End Points. The American Journal of Surgical Pathology 30:12, 1491-1501
    CrossRef

  32. 32

    Robert Gryfe. (2006) Clinical Implications of Our Advancing Knowledge of Colorectal Cancer Genetics: Inherited Syndromes, Prognosis, Prevention, Screening and Therapeutics. Surgical Clinics of North America 86:4, 787-817
    CrossRef

  33. 33

    Carol A. Durno, Steven Gallinger. (2006) Genetic Predisposition to Colorectal Cancer. Journal of Pediatric Gastroenterology and Nutrition 43:1, 5-15
    CrossRef

  34. 34

    Megan Q Zhang, Zong-Ming E Chen, Hanlin L Wang. (2006) Immunohistochemical investigation of tumorigenic pathways in small intestinal adenocarcinoma: a comparison with colorectal adenocarcinoma. Modern Pathology 19:4, 573-580
    CrossRef

  35. 35

    Coral V.A. Wynter, Takeshi Kambara, Michael D. Walsh, Barbara A. Leggett, Joanne Young, Jeremy R. Jass. (2006) DNA methylation patterns in adenomas from FAP, multiple adenoma and sporadic colorectal carcinoma patients. International Journal of Cancer 118:4, 907-915
    CrossRef

  36. 36

    Mara Fornasarig, Alessandro M. Minisini, Alessandra Viel, Michele Quaia, Vincenzo Canzonieri, Andrea Veronesi. (2006) Twelve Years of Endoscopic Surveillance in a Family Carrying Biallelic Y165C MYH Defect: Report of a Case. Diseases of the Colon & Rectum 49:2, 272-275
    CrossRef

  37. 37

    Takayuki Matsumoto, Shotaro Nakamura, Motohiro Esaki, Takashi Yao, Mitsuo Iida. (2006) Effect of the non-steroidal anti-inflammatory drug sulindac on colorectal adenomas of uncolectomized familial adenomatous polyposis. Journal of Gastroenterology and Hepatology 21:1, 251-257
    CrossRef

  38. 38

    Takuji Tanaka, Hiroyuki Kohno, Rikako Suzuki, Kazuya Hata, Shigeyuki Sugie, Naoko Niho, Katsuhisa Sakano, Mami Takahashi, Keiji Wakabayashi. (2006) Dextran sodium sulfate strongly promotes colorectal carcinogenesis inApcMin/+ mice: Inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms. International Journal of Cancer 118:1, 25-34
    CrossRef

  39. 39

    C. Richard Boland. (2005) Evolution of the Nomenclature for the Hereditary Colorectal Cancer Syndromes. Familial Cancer 4:3, 211-218
    CrossRef

  40. 40

    Fotini Gounari, Rui Chang, Janet Cowan, Zhuyan Guo, Marei Dose, Elias Gounaris, Khashayarsha Khazaie. (2005) Loss of adenomatous polyposis coli gene function disrupts thymic development. Nature Immunology 6:8, 800-809
    CrossRef

  41. 41

    Randall Burt, Deborah W. Neklason. (2005) Genetic Testing for Inherited Colon Cancer. Gastroenterology 128:6, 1696-1716
    CrossRef

  42. 42

    Takashi Kumagai, Ayalew Tefferi, Letetia Jones, H. Phillip Koeffler. (2005) Methylation analysis of the cell cycle control genes in myelofibrosis with myeloid metaplasia. Leukemia Research 29:5, 511-515
    CrossRef

  43. 43

    Lisa L. Strate, Sapna Syngal. (2005) Hereditary colorectal cancer syndromes. Cancer Causes & Control 16:3, 201-213
    CrossRef

  44. 44

    Anders Merg, Henry T. Lynch, Jane F. Lynch, James R. Howe. (2005) Hereditary colon cancer—Part I. Current Problems in Surgery 42:4, 195-256
    CrossRef

  45. 45

    Yang Yang, Seisho Takeuchi, Kunihiro Tsukasaki, Yasuaki Yamada, Tomoko Hata, Naoki Mori, Atsuki Fukushima, Hiromi Seo, H.Phillip Koeffler, Hirokuni Taguchi. (2005) Methylation analysis of the adenomatous polyposis coli (APC) gene in adult T-cell leukemia/lymphoma. Leukemia Research 29:1, 47-51
    CrossRef

  46. 46

    Brian Somoano, Kristin Baker Niendorf, Hensin Tsao. (2005) Hereditary cancer syndromes of the skin. Clinics in Dermatology 23:1, 85-106
    CrossRef

  47. 47

    Sadanand Gite, Alex Garvin, Kenneth Rothschild. 2004. Protein Truncation Test (PTT). , 1089-1094.
    CrossRef

  48. 48

    Yoshinori Murakami, Kana Isogai, Hiroyuki Tomita, Mika Sakurai-Yageta, Tomoko Maruyama, Akio Hidaka, Kiyoshi Nose, Kokichi Sugano, Akihiro Kaneko. (2004) Detection of allelic imbalance in the gene expression of hMSH2 or RB1 in lymphocytes from pedigrees of hereditary, nonpolyposis, colorectal cancer and retinoblastoma by an RNA difference plot. Journal of Human Genetics 49:11, 635-641
    CrossRef

  49. 49

    Yong-hui Jiang, Jan Bressler, Arthur L. Beaudet. (2004) EPIGENETICS AND HUMAN DISEASE. Annual Review of Genomics and Human Genetics 5:1, 479-510
    CrossRef

  50. 50

    Ellen T. Matloff, Karina L. Brierley, Christina M. Chimera. (2004) A Clinician??s Guide to Hereditary Colon Cancer. The Cancer Journal 10:5, 280-287
    CrossRef

  51. 51

    Shannon Cowie, Snezana Drmanac, Donald Swanson, Kathleen Delgrosso, Steve Huang, Desirée du Sart, Radoje Drmanac, Saul Surrey, Paolo Fortina. (2004) Identification of APC gene mutations in colorectal cancer using universal microarray-based combinatorial sequencing-by-hybridization. Human Mutation 24:3, 261-271
    CrossRef

  52. 52

    Rolf Vossen, Johan T. den Dunnen. 2004. Protein Truncation Test. .
    CrossRef

  53. 53

    Natalia A. Ignatenko, Hui Zhang, George S. Watts, Bethany A. Skovan, David E. Stringer, Eugene W. Gerner. (2004) The chemopreventive agent ?-difluoromethylornithine blocks Ki-ras-dependent tumor formation and specific gene expression in Caco-2 cells. Molecular Carcinogenesis 39:4, 221-233
    CrossRef

  54. 54

    Thomas M. Attard, Carmen Cuffari, Tanya Tajouri, Julie A. Stoner, Marcia T. Eisenberg, John H. Yardley, Susan C. Abraham, Deborah Perry, Jon Vanderhoof, Henry Lynch. (2004) Multicenter Experience with Upper Gastrointestinal Polyps in Pediatric Patients with Familial Adenomatous Polyposis. The American Journal of Gastroenterology 99:4, 681-686
    CrossRef

  55. 55

    Heikki J J??rvinen, P??ivi Peltom??ki. (2004) The complex genotype???phenotype relationship in familial adenomatous polyposis. European Journal of Gastroenterology & Hepatology 16:1, 5-8
    CrossRef

  56. 56

    Cabot, Richard C.Harris, Nancy Lee, McNeely, William F., Shepard, Jo-Anne O., Ebeling, Sally H.Ellender, Stacey M.Peters, Christine C., Chung, Daniel C., Mino, Mari, Shannon, Kristen M., . (2003) Case 34-2003. New England Journal of Medicine 349:18, 1750-1760
    Full Text

  57. 57

    S.-M. Herrmann, Y.D. Adler, K. Schmidt-Petersen, V. Nicaud, C. Morrison, M. Paul, Ch.C. Zouboulis. (2003) The concomitant occurrence of multiple epidermal cysts, osteomas and thyroid gland nodules is not diagnostic for Gardner syndrome in the absence of intestinal polyposis: a clinical and genetic report. British Journal of Dermatology 149:4, 877-883
    CrossRef

  58. 58

    William M. Grady. (2003) Genetic testing for high-risk colon cancer patients1 1Abbreviations used in this paper: FAP, familial adenomatous polyposis; HMPS, hereditary mixed polyposis syndrome; HNPCC, hereditary nonpolyposis colon cancer; JPS, juvenile polyposis; MMR, mutation mismatch repair; MSI, microsatellite instability; PJS, Peutz-Jeghers syndrome; TGF, transforming growth factor.. Gastroenterology 124:6, 1574-1594
    CrossRef

  59. 59

    Rosemary Jagus, Gregory S. Beckler. 2003. Overview of Eukaryotic In Vitro Translation and Expression Systems. .
    CrossRef

  60. 60

    Christopher A. Friedrich. (2003) The Role of DNA Testing in Breast, Ovarian, and Colon Cancers. The American Journal of the Medical Sciences 325:3, 120-124
    CrossRef

  61. 61

    Ann-Marie Codori, Kristin L. Zawacki, Gloria M. Petersen, Diana L. Miglioretti, Judith A. Bacon, Jill D. Trimbath, Susan V. Booker, Kimberly Picarello, Francis M. Giardiello. (2003) Genetic testing for hereditary colorectal cancer in children: Long-term psychological effects. American Journal of Medical Genetics 116A:2, 117-128
    CrossRef

  62. 62

    B Xu, A Miyauchi, S Uchino, Y Sekihara, M Hirokawa, T Sano, K Yoshimoto. (2003) A predominant increase in the APC gene isoform with exon 9a in a case of attenuated familial adenomatous polyposis. Clinical Genetics 63:1, 71-72
    CrossRef

  63. 63

    Bing Xu, Katsuhiko Yoshimoto, Akira Miyauchi, Seiji Kuma, Noriko Mizusawa, Mitsuyoshi Hirokawa, Toshiaki Sano. (2003) Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the ?-catenin gene. The Journal of Pathology 199:1, 58-67
    CrossRef

  64. 64

    Lisa A Boardman. (2002) Heritable colorectal cancer syndromes: recognition and preventive management. Gastroenterology Clinics of North America 31:4, 1107-1131
    CrossRef

  65. 65

    Rodney J. Scott, Claire M. Vajdic, Bruce K. Armstrong, Christopher J. Ainsworth, Cliff J. Meldrum, Joanne F. Aitken, Anne Kricker. (2002) BRCA2 mutations in a population-based series of patients with ocular melanoma. International Journal of Cancer 102:2, 188-191
    CrossRef

  66. 66

    J. D. Trimbath, F. M. Giardiello. (2002) Genetic testing and counselling for hereditary colorectal cancer. Alimentary Pharmacology and Therapeutics 16:11, 1843-1857
    CrossRef

  67. 67

    Chew-Wun Wu, Gen-Der Chen, Cathy S.-J. Fann, Anna F.-Y. Lee, Chin-Wen Chi, Jacqueline M. Liu, Ulli Weier, Jeou-Yuan Chen. (2002) Clinical implications of chromosomal abnormalities in gastric adenocarcinomas. Genes, Chromosomes and Cancer 35:3, 219-231
    CrossRef

  68. 68

    Motohiro Esaki, Takayuki Matsumoto, Mitsuru Mizuno, Yoichiro Kobori, Ryuji Yoshimura, Takashi Yao, Mitsuo Iida. (2002) Effect of Sulindac Treatment for Attenuated Familial Adenomatous Polyposis With a New Germline APC Mutation at Codon 161. Diseases of the Colon & Rectum 45:10, 1397-1406
    CrossRef

  69. 69

    Brad Trowbridge, Randall W. Burt. (2002) Colorectal cancer screening. Surgical Clinics of North America 82:5, 943-957
    CrossRef

  70. 70

    Steven H. Erdman, John A. Barnard. (2002) Gastrointestinal polyps and polyposis syndromes in children. Current Opinion in Pediatrics 14:5, 576-582
    CrossRef

  71. 71

    Masumi Suzui, Masataka Okuno, Takuji Tanaka, Hitoshi Nakagama, Hisataka Moriwaki. (2002) Enhanced colon carcinogenesis induced by azoxymethane in min mice occurs via a mechanism independent of β-catenin mutation. Cancer Letters 183:1, 31-41
    CrossRef

  72. 72

    Dennis M Robertson. (2002) Non-Cancerous Ophthalmic Clues to Non-Ocular Cancer. Survey of Ophthalmology 47:5, 397-430
    CrossRef

  73. 73

    William M. Grady, Sanford D. Markowitz. (2002) G ENETIC AND E PIGENETIC A LTERATIONS IN C OLON C ANCER. Annual Review of Genomics and Human Genetics 3:1, 101-128
    CrossRef

  74. 74

    John P Lynch, Timothy C Hoops. (2002) The genetic pathogenesis of colorectal cancer. Hematology/Oncology Clinics of North America 16:4, 775-810
    CrossRef

  75. 75

    Kathryn A Peterson, James A DiSario. (2002) Secondary prevention: screening and surveillance of persons at average and high risk for colorectal cancer. Hematology/Oncology Clinics of North America 16:4, 841-865
    CrossRef

  76. 76

    C. Luceri, C. De Filippo, F. Guglielmi, G. Caderni, L. Messerini, A. Biggeri, E. Mini, F. Tonelli, F. Cianchi, P. Dolara. (2002) Microsatellite instability in a population of sporadic colorectal cancers correlation between genetic and pathological profiles. Digestive and Liver Disease 34:8, 553-559
    CrossRef

  77. 77

    Amy V. Gerstein, Teresa Acosta Almeida, Guojing Zhao, Eric Chess, Ie-Ming Shih, Kent Buhler, Kenneth Pienta, Mark A. Rubin, Robert Vessella, Nickolas Papadopoulos. (2002) APC/CTNNB1 (?-catenin) pathway alterations in human prostate cancers. Genes, Chromosomes and Cancer 34:1, 9-16
    CrossRef

  78. 78

    Kimberly E. Fultz, Eugene W. Gerner. (2002) APC-dependent regulation of ornithine decarboxylase in human colon tumor cells. Molecular Carcinogenesis 34:1, 10-18
    CrossRef

  79. 79

    Sabine Kahmann, Peter Herter, Cornelius Kuhnen, Klaus-Michael Mller, Gert Muhr, Dirk Martin, Matthias Soddemann, Oliver Mller. (2002) A non-radioactive protein truncation test for the sensitive detection of all stop and frameshift mutations. Human Mutation 19:2, 165-172
    CrossRef

  80. 80

    Traverso, Giovanni, Shuber, Anthony, Levin, Bernard, Johnson, Constance, Olsson, Louise, Schoetz, David J. Jr., Hamilton, Stanley R., Boynton, Kevin, Kinzler, Kenneth W., Vogelstein, Bert, . (2002) Detection of APC Mutations in Fecal DNA from Patients with Colorectal Tumors. New England Journal of Medicine 346:5, 311-320
    Full Text

  81. 81

    Kenneth M. Sterling, Kenneth R. Cutroneo. (2002) Differentiation-dependent induction ofCYP1A1 in cultured rat small intestinal epithelial cells, colonocytes, and human colon carcinoma cells: Basement membrane-mediated apoptosis. Journal of Cellular Biochemistry 86:3, 440-450
    CrossRef

  82. 82

    G. Wu, W. Wu, M. Hegde, M. Fawkner, B. Chong, D. Love, L.-K. Su, P. Lynch, K. Snow, C.S. Richards. (2001) Detection of Sequence Variations in the Adenomatous Polyposis Coli ( APC ) Gene Using Denaturing High-Performance Liquid Chromatography. Genetic Testing 5:4, 281-290
    CrossRef

  83. 83

    Hsingchi Lin, Patrice J. Morin. (2001) A novel homozygous deletion at chromosomal band 6q27 in an ovarian cancer cell line delineates the position of a putative tumor suppressor gene. Cancer Letters 173:1, 63-70
    CrossRef

  84. 84

    Li-Kuo Su, Eddie K. Abdalla, Calvin H. L. Law, Wendy Kohlmann, Asif Rashid, Jean-Nicolas Vauthey. (2001) Biallelic inactivation of theAPC gene is associated with hepatocellular carcinoma in familial adenomatous polyposis coli. Cancer 92:2, 332-339
    CrossRef

  85. 85

    Bret M. Wehrli, Sharon W. Weiss, Suzanne Yandow, Cheryl M. Coffin. (2001) Gardner-Associated Fibromas (GAF) in Young Patients. The American Journal of Surgical Pathology 25:5, 645-651
    CrossRef

  86. 86

    Ettore Seregni, Leonardo Ferrari, Antonia Martinetti, Emilio Bombardieri. (2001) Diagnostic and prognostic tumor markers in the gastrointestinal tract. Seminars in Surgical Oncology 20:2, 147-166
    CrossRef

  87. 87

    Rogério Rabelo, William Foulkes, Philip H. Gordon, Nora Wong, Zhi Qiang Yuan, Elizabeth MacNamara, George Chong, Leonard Pinsky, Dana Lasko. (2001) Role of molecular diagnostic testing in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer families. Diseases of the Colon & Rectum 44:3, 437-446
    CrossRef

  88. 88

    Yann R. Parc, Sylviane Olschwang, Beno??t Desaint, Ghislain Schmitt, Rolland G. Parc, Emmanuel Tiret. (2001) Familial Adenomatous Polyposis: Prevalence of Adenomas in the Ileal Pouch After Restorative Proctocolectomy. Annals of Surgery 233:3, 360-364
    CrossRef

  89. 89

    Glenn M. Eisen, John F. Johanson. (2001) EVIDENCE-BASED APPROACH TO SCREENING AND SURVEILLANCE FOR COLORECTAL CANCER. Evidence-Based Gastroenterology 2:1, 44-49
    CrossRef

  90. 90

    Lisa A. Boardman, Shauna Schmidt, Noralene M. Lindor, Larry J. Burgart, Julie M. Cunningham, Tammy Price-Troska, Karen Snow, David A. Ahlquist, Stephen N. Thibodeau. (2001) A search for germline APC mutations in early onset colorectal cancer or familial colorectal cancer with normal DNA mismatch repair. Genes, Chromosomes and Cancer 30:2, 181-186
    CrossRef

  91. 91

    S.S. Prime, N.S. Thakker, M. Pring, P.G. Guest, I.C. Paterson. (2001) A review of inherited cancer syndromes and their relevance to oral squamous cell carcinoma. Oral Oncology 37:1, 1-16
    CrossRef

  92. 92

    Abdoreza Davoodi-Semiromi, George W. Lanyon, Rosemary Davidson, Michael J. Connor. (2000) Aberrant RNA splicing in thehMSH2 gene: Molecular identification of three aberrant RNA in Scottish patients with colorectal cancer in the West of Scotland. American Journal of Medical Genetics 95:1, 49-52
    CrossRef

  93. 93

    James S. Wu, Victor W. Fazio. (2000) Colon cancer. Diseases of the Colon & Rectum 43:11, 1473-1486
    CrossRef

  94. 94

    Warren Hyer, Iain Beveridge, Paola Domizio, Robin Phillips. (2000) Clinical Management and Genetics of Gastrointestinal Polyps in Children. Journal of Pediatric Gastroenterology and Nutrition 31:5, 469-479
    CrossRef

  95. 95

    &NA;. (2000) Social, Ethical and Legal Issues Committee, American College of Medical Genetics. Genetics in Medicine 2:6, 367-368
    CrossRef

  96. 96

    Naoyuki Umetani, Toshiaki Watanabe, Shin Sasaki, Hirokazu Nagawa. (2000) Rectosigmoidal adenomatous polyposis: A novel entity of polyposis?. Diseases of the Colon & Rectum 43:10, 1439-1443
    CrossRef

  97. 97

    Li-Kuo Su, Christopher J. Barnes, Weizhe Yao, Yi Qi, Patrick M. Lynch, Gideon Steinbach. (2000) Inactivation of Germline Mutant APC Alleles by Attenuated Somatic Mutations: A Molecular Genetic Mechanism for Attenuated Familial Adenomatous Polyposis. The American Journal of Human Genetics 67:3, 582-590
    CrossRef

  98. 98

    Lauri A Aaltonen. (2000) Hereditary intestinal cancer. Seminars in Cancer Biology 10:4, 289-298
    CrossRef

  99. 99

    Thomas J. McGarrity, Francesca M. Ruggiero, William Y. Chey, Rajesh Bajaj, J. Edward Kelly, Gordon L. Kauffman. (2000) Giant fundic polyp complicating attenuated familial adenomatous polyposis. The American Journal of Gastroenterology 95:7, 1824-1828
    CrossRef

  100. 100

    Keiji Furuuchi, Mitsuhiro Tada, Hidehisa Yamada, Akihiko Kataoka, Narumi Furuuchi, Jun-ichi Hamada, Masato Takahashi, Satoru Todo, Tetsuya Moriuchi. (2000) Somatic Mutations of the APC Gene in Primary Breast Cancers. The American Journal of Pathology 156:6, 1997-2005
    CrossRef

  101. 101

    WOLFGANG G. BALLHAUSEN. (2000) Genetic Testing for Familial Adenomatous Polyposis. Annals of the New York Academy of Sciences 910:1, 36-49
    CrossRef

  102. 102

    Geeta Lal, Steven Gallinger. (2000) Familial adenomatous polyposis. Seminars in Surgical Oncology 18:4, 314-323
    CrossRef

  103. 103

    Zongyou Guo, Sonny L. Johansson, Johng S. Rhim, Jamboor K. Vishwanatha. (2000) Fragile histidine triad gene expression in primary prostate cancer and in an in vitro model. The Prostate 43:2, 101-110
    CrossRef

  104. 104

    Douglas K. Rex, David A. Johnson, David A. Lieberman, Randall W. Burt, Amnon Sonnenberg. (2000) Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. In conjunction with ACG Consumer Brochure: "ACG Recommendations on Colorectal Cancer Screening for Average and Higher Risk Patients in Clinical Practice".. The American Journal of Gastroenterology 95:4, 868-877
    CrossRef

  105. 105

    Jean Couture, Angela Mitri, Real Lagace, Ron Smits, Terri Berk, Henri-Louis Bouchard, Riccardo Fodde, Benjamin Alman, Bharati Bapat. (2000) A germline mutation at the extreme 3′ end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor. Clinical Genetics 57:3, 205-212
    CrossRef

  106. 106

    E. Villa. (2000) Molecular screening for colon cancer detection. Digestive and Liver Disease 32:2, 173-177
    CrossRef

  107. 107

    Takashi Tamiya, Shuji Hamazaki, Yasuhiro Ono, Koji Tokunaga, Kengo Matsumoto, Tomohisa Furuta, Takashi Ohmoto. (2000) Ganglioglioma in a patient with Turcot syndrome. Journal of Neurosurgery 92:1, 170-175
    CrossRef

  108. 108

    Gloria M. Petersen, Jill D. Brensinger, Karen A. Johnson, Francis M. Giardiello. (1999) Genetic testing and counseling for hereditary forms of colorectal cancer. Cancer 86:S11, 2540-2550
    CrossRef

  109. 109

    Sima Salahshor, Ulf Kressner, Lars Phlman, Bengt Glimelius, Gudrun Lindmark, Annika Lindblom. (1999) Colorectal cancer with and without microsatellite instability involves different genes. Genes, Chromosomes and Cancer 26:3, 247-252
    CrossRef

  110. 110

    James F. Helm, Robert S. Sandler. (1999) COLORECTAL CANCER SCREENING. Medical Clinics of North America 83:6, 1403-1422
    CrossRef

  111. 111

    Gloria M. Petersen, Jill D. Brensinger, Karen A. Johnson, Francis M. Giardiello. (1999) Genetic testing and counseling for hereditary forms of colorectal cancer. Cancer 86:S8, 1720-1730
    CrossRef

  112. 112

    Vincent W. Yang. (1999) The molecular genetics of colorectal cancer. Current Gastroenterology Reports 1:5, 449-454
    CrossRef

  113. 113

    Xia Cao, Kong Weng Eu, Francis Seow-Choen, Peh Yean Cheah. (1999) Germline mutations are frequent in theAPC gene but absent in the ?-Catenin gene in familial adenomatous polyposis patients. Genes, Chromosomes and Cancer 25:4, 396-398
    CrossRef

  114. 114

    Hideyuki Nei, Tsuyoshi Saito, Hiroshi Yamasaki, Hisanobu Mizumoto, Eiki Ito, Ryuichi Kudo. (1999) Nuclear localization of ?-catenin in normal and carcinogenic endometrium. Molecular Carcinogenesis 25:3, 207-218
    CrossRef

  115. 115

    M. Cravo, P. Lage, C. Albuquerque, P. Chaves, I. Claro, T. Gomes, C. Gaspar, P. Fidalgo, J. Soares, C. Nobre-Leito. (1999) BAT-26 identifies sporadic colorectal cancers with mutator phenotype: a correlative study with clinico-pathological features and mutations in mismatch repair genes. The Journal of Pathology 188:3, 252-257
    CrossRef

  116. 116

    José G. Guillem, Andrew J. Smith, Jorge Puig-La Calle, Leyo Ruo. (1999) Gastrointestinal polyposis syndromes. Current Problems in Surgery 36:4, 217-323
    CrossRef

  117. 117

    Johannes F. Gebert, Cecile Dupon, Martina Kadmon, Matthias Hahn, Christian Herfarth, Magnus von Knebel Doeberitz, Hans K. Schackert. (1999) Combined Molecular and Clinical Approaches for the Identification of Families with Familial Adenomatous Polyposis Coli. Annals of Surgery 229:3, 350-361
    CrossRef

  118. 118

    Smeena Sabir, William D. James, Lynn M. Schuchter. (1999) Cutaneous manifestations of cancer. Current Opinion in Oncology 11:2, 139
    CrossRef

  119. 119

    Henry T. Lynch, Patrick M. Lynch. (1999) Invited editorial. Diseases of the Colon & Rectum 42:3, 310-312
    CrossRef

  120. 120

    Theresa Berk, Zane Cohen, Bharati Bapat, Steven Gallinger. (1999) Negative genetic test result in familial adenomatous polyposis. Diseases of the Colon & Rectum 42:3, 307-310
    CrossRef

  121. 121

    Edward J. Hoffenberg, Angela Sauaia, Terese Maltzman, Kirsten Knoll, Dennis J. Ahnen. (1999) Symptomatic Colonic Polyps in Childhood: Not So Benign. Journal of Pediatric Gastroenterology & Nutrition 28:2, 175-181
    CrossRef

  122. 122

    Johan T. Den Dunnen, Gert-Jan B. Van Ommen. (1999) The protein truncation test: A review. Human Mutation 14:2, 95-102
    CrossRef

  123. 123

    Ghada M.H. Abdel-Salam, Gábor Vogt, Adrienne Halász, Andrew E. Czeizel. (1999) Microcephaly with normal intelligence, and chorioretinopathy. Ophthalmic Genetics 20:4, 259-264
    CrossRef

  124. 124

    Monica Giarola, Lisa Stagi, Silvano Presciuttini, Patrizia Mondini, Maria T. Radice, Paola Sala, Marco A. Pierotti, Lucio Bertario, Paolo Radice. (1999) Screening for mutations of theAPC gene in 66 Italian familial adenomatous polyposis patients: Evidence for phenotypic differences in cases with and without identified mutation. Human Mutation 13:2, 116-123
    CrossRef

  125. 125

    John F. Bateman, Susanna Freddi, Shireen R. Lamand, Peter Byers, Steven Nasioulas, Jenny Douglas, Robyn Otway, Maija Kohonen-Corish, Edward Edkins, Susan Forrest. (1999) Reliable and sensitive detection of premature termination mutations using a protein truncation test designed to overcome problems of nonsense-mediated mRNA instability. Human Mutation 13:4, 311-317
    CrossRef

  126. 126

    Claudio Soravia, Sonia L. Sugg, Terri Berk, Angela Mitri, Hong Cheng, Steven Gallinger, Zane Cohen, Sylvia L. Asa, Bharati V. Bapat. (1999) Familial Adenomatous Polyposis-Associated Thyroid Cancer. The American Journal of Pathology 154:1, 127-135
    CrossRef

  127. 127

    Pierre Hutter, Alexia Couturier, Véronique Membrez, François Joris, André-Pascal Sappino, Pierre O. Chappuis. (1998) Excess ofhMLH1 germline mutations in Swiss families with hereditary non-polyposis colorectal cancer. International Journal of Cancer 78:6, 680-684
    CrossRef

  128. 128

    Jan Zedenius, Trisha Dwight, Bruce G. Robinson, Leigh Delbridge, Martin Backdahl, Goran Wallin, Catharina Larsson, Gunther Weber. (1998) A Rapid Method for DNA Extraction from Fine-Needle Aspiration Biopsies of Thyroid Tumors, and Subsequent RET Mutation Analysis. Cancer Detection <html_ent glyph="@amp;" ascii="&"/> Prevention 22:6, 544-548
    CrossRef

  129. 129

    Peter Juo, Calvin J. Kuo, Junying Yuan, John Blenis. (1998) Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Current Biology 8:18, 1001-1008
    CrossRef

  130. 130

    Alexandra Suspiro, Paulo Fidalgo, Marilia Cravo, Cristina Albuquerque, Eunice Ramalho, C. Nobre Leitao, F. Costa Mira. (1998) The muir-torre syndrome: a rare variant of hereditary nonpolyposis colorectal cancer associated with hmsh2 mutation. The American Journal of Gastroenterology 93:9, 1572-1574
    CrossRef

  131. 131

    D. Aktas, A. Ayhan, E. Tuncbilek, A. Ozdemir, B. Uzunalimoglu. (1998) No evidence for overexpression of the p53 protein and mutations in exons 4-9 of the p53 gene in a large family with adenomatous polyposis. The American Journal of Gastroenterology 93:9, 1524-1526
    CrossRef

  132. 132

    Anne-Marie Lefebvre, Inhua Chen, Pierre Desreumaux, Jamila Najib, Jean-Charles Fruchart, Karel Geboes, Mike Briggs, Rich Heyman, Johan Auwerx. (1998) Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nature Medicine 4:9, 1053-1057
    CrossRef

  133. 133

    Simona Pedemonte, Stefania Sciallero, Viviana Gismondi, Paola Stagnaro, Roberta Biticchi, Abdelhamid Haeouaine, Luigina Bonelli, Guido Nicolo˘, Joanna Groden, Paolo Bruzzi, Hugo Aste, Liliana Varesco. (1998) Novel germlineAPC variants in patients with multiple adenomas. Genes, Chromosomes and Cancer 22:4, 257-267
    CrossRef

  134. 134

    Michael Kirchgesser, Andreas Albers, Rolf Vossen, Johan den Dunnen, Gert-Jan van Ommen, Johannes Gebert, Cecile Dupont, Christian Herfarth, Magnus von Knebel-Doeberitz, Gudrun Schmitz-Agheguian. (1998) Optimized Non-Radioactive Protein Truncation Test for Mutation Analysis of the Adenomatous Polyposis Coli (APC) Gene. Clinical Chemistry and Laboratory Medicine 36:8, 567-570
    CrossRef

  135. 135

    Claudio Soravia, Terri Berk, Lisa Madlensky, Angela Mitri, Hong Cheng, Steven Gallinger, Zane Cohen, Bharati Bapat. (1998) Genotype-Phenotype Correlations in Attenuated Adenomatous Polyposis Coli. The American Journal of Human Genetics 62:6, 1290-1301
    CrossRef

  136. 136

    Raymond J. Playford. (1998) Tales from the human crypt—intestinal stem cell repertoire and the origins of human cancer. The Journal of Pathology 185:2, 119-122
    CrossRef

  137. 137

    C Kraus. (1998) Rapid RT-PCR-based protein truncation test in the screening for 5′ located mutations of the APC gene. Molecular and Cellular Probes 12:3, 143-147
    CrossRef

  138. 138

    Barbara A. Gruner, Thomas S. DeNapoli, Walter Andrews, Gail Tomlinson, Laura Bowman, Steven D. Weitman. (1998) Hepatocellular Carcinoma in Children Associated With Gardner Syndrome or Familial Adenomatous Polyposis. Journal of Pediatric Hematology/Oncology 20:3, 274
    CrossRef

  139. 139

    Takao Suzuki, Chikashi Ishioka, Satoshi Kato, Yasushi Mitachi, Hideki Shimodaira, Masato Sakayori, Akira Shimada, Mitsuo Asamura, Ryunosuke Kanamaru. (1998) Detection ofAPC mutations by a yeast-based protein truncation test (YPTT). Genes, Chromosomes and Cancer 21:4, 290-297
    CrossRef

  140. 140

    Lucio Scopsi, Luca Cozzaglio, Paola Collini, Maria Gullo, Italia Bongarzone, Monica Giarola, Paolo Radice, Leandro Gennari. (1998) Concurrent pheochromocytoma, paraganglioma, papillary thyroid carcinoma, and desmoid tumor: A case report with analyses at the molecular level. Endocrine Pathology 9:1, 79-90
    CrossRef

  141. 141

    Kim E. Nichols, Frederick P. Li, Daniel A. Haber, Lisa Diller. (1998) Childhoood cancer predisposition: Applications of molecular testing and future implications. The Journal of Pediatrics 132:3, 389-397
    CrossRef

  142. 142

    Tsung-Teh Wu, Susan Kornacki, Asif Rashid, John H. Yardley, Stanley R. Hamilton. (1998) Dysplasia and Dysregulation of Proliferation in Foveolar and Surface Epithelia of Fundic Gland Polyps From Patients With Familial Adenomatous Polyposis. The American Journal of Surgical Pathology 22:3, 293-298
    CrossRef

  143. 143

    Carlos Caldas, Chi W So, Angus MacGregor, Anthony M Ford, Bernadette McDonald, Li C Chan, Leanne M Wiedemann. (1998) Exon scrambling of MLL transcripts occur commonly and mimic partial genomic duplication of the gene. Gene 208:2, 167-176
    CrossRef

  144. 144

    Martin Delatycki, Steven Nasioulas, Karina Forshaw, Susan Forrest. (1998) Two novel mutations in exons 5 and 15 of the adenomatous polyposis coli (APC) gene. Human Mutation 11:S1, S314-S316
    CrossRef

  145. 145

    Thérèse M. F. Tuohy, Joanna Groden. (1998) Exons – Introns = Lexons: In-frame concatenation of exons by PCR. Human Mutation 12:2, 122-127
    CrossRef

  146. 146

    Maureen J. O'Sullivan, Tanya M. Mulcahy, J. Cambell, Christoir B. O'Suilleabhain, William O. Kirwan, Cuimin T. Doyle, Tommie V. McCarthy. (1998) Detection of five novel germline mutations of the APC gene in Irish familial adenomatous polyposis families. Human Mutation 11:S1, S251-S253
    CrossRef

  147. 147

    Olga Monakov, Eliahou Shemesh, Simon Bar-Meir, Ephraim Gazit. (1998) Novel nonsense mutation in exon 15 of the APC gene in one Jewish family. Human Mutation 11:S1, S55-S55
    CrossRef

  148. 148

    Laura Ottini, Cristina D'Amico, Cristiana Noviello, Claudia Pizzi, Clorindo Pagliarulo, Maria Cristina Curia, Gennaro Limite, Angelo Raffaele Bianco, Luigi Frati, Felice Giacomo Caramia, Alessandro Cama, Alma Contegiacomo, Renato Mariani-Costantini. (1998) Novel deletion at codon 1254 of the BRCA1 gene in an Italian breast cancer kindred. Human Mutation 11:S1, S237-S239
    CrossRef

  149. 149

    B Bradley. (1997) Molecular advances in the etiology and treatment of colorectal cancer. Surgical Oncology 6:3, 143-156
    CrossRef

  150. 150

    Steven J. Laken, Gloria M. Petersen, Stephen B. Gruber, Carole Oddoux, Harry Ostrer, Francis M. Giardiello, Stanley R. Hamilton, Heather Hampel, Arnold Markowitz, David Klimstra, Suresh Jhanwar, Sidney Winawer, Kenneth Offit, Michael C. Luce, Kenneth W. Kinzler, Bert Vogelstein. (1997) Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nature Genetics 17:1, 79-83
    CrossRef

  151. 151

    Monica M. Bertagnolli, Najjia N. Mahmoud, John M. Daly. (1997) SURGICAL ASPECTS OF COLORECTAL CARCINOMA. Hematology/Oncology Clinics of North America 11:4, 655-677
    CrossRef

  152. 152

    Joyann A. Kroser, Dale R. Bachwich, Gary R. Lichtenstein. (1997) RISK FACTORS FOR THE DEVELOPMENT OF COLORECTAL CARCINOMA AND THEIR MODIFICATION. Hematology/Oncology Clinics of North America 11:4, 547-577
    CrossRef

  153. 153

    Linda Shalon, James Markowitz, Martin Bialer, Ellen Kahn, Mark Weinblatt, Francis M. Giardiello, Michael C. Luce, Fredric Daum. (1997) Ovarian Neoplasm and Endometrioid Carcinoma in a Patient with Turcot Syndrome. Journal of Pediatric Gastroenterology &amp Nutrition 25:2, 224-227
    CrossRef

  154. 154

    Valeria Pensotti, Paolo Radice, Silvano Presciuttini, Daniele Calistri, Isabella Gazzoli, Ana Paula Grimalt Perez, Patrizia Mondini, Giovanni Buonsanti, Paola Sala, Carlo Rossetti, Guglielmina N. Ranzani, Lucio Bertario, Marco A. Pierotti. (1997) Mean age of tumor onset in hereditary nonpolyposis colorectal cancer (HNPCC) families correlates with the presence of mutations in DNA mismatch repair genes. Genes, Chromosomes and Cancer 19:3, 135-142
    CrossRef

  155. 155

    Side, Lucy, Taylor, Brigit, Cayouette, Matthew, Conner, Edward, Thompson, Patricia, Luce, Michael, Shannon, Kevin, . (1997) Homozygous Inactivation of the NF1 Gene in Bone Marrow Cells from Children with Neurofibromatosis Type 1 and Malignant Myeloid Disorders. New England Journal of Medicine 336:24, 1713-1720
    Full Text

  156. 156

    B.T. Teh, G. Birrell, A. Farrell, J.H. Leonard, M.K. Walters, J.M. Palmer, J.R. Ramsay, D.J. Schlect, C. Furnival, M.F. Lavin, I. Bennett, N.K. Hayward. (1997) Breast cancer in six women with neurofibromatosis type 1. The Breast 6:3, 155-160
    CrossRef

  157. 157

    Giardiello, Francis M., Brensinger, Jill D., Petersen, Gloria M., Luce, Michael C., Hylind, Linda M., Bacon, Judith A., Booker, Susan V., Parker, Rodger D., Hamilton, Stanley R., . (1997) The Use and Interpretation of Commercial APC Gene Testing for Familial Adenomatous Polyposis. New England Journal of Medicine 336:12, 823-827
    Full Text

  158. 158

    Ann-Marie Codori. (1997) PSYCHOLOGICAL OPPORTUNITIES AND HAZARDS IN PREDICTIVE GENETIC TESTING FOR CANCER RISK. Gastroenterology Clinics of North America 26:1, 19-39
    CrossRef

  159. 159

    James R. Howe, José G. Guillem. (1997) THE GENETICS OF COLORECTAL CANCER. Surgical Clinics of North America 77:1, 175-195
    CrossRef

  160. 160

    Andrew J. Rowan, Walter F. Bodmer. (1997) Introduction of amyc reporter tag to improve the quality of mutation detection using the protein truncation test. Human Mutation 9:2, 172-176
    CrossRef

  161. 161

    Rob. B. van der Luijt, P. Meera Khan, Hans F. A. Vasen, Carli M. J. Tops, Inge S. J. van Leeuwen-Cornelisse, Juul Th. Wijnen, Heleen M. van der Klift, Rob J. Plug, Gerrit Griffioen, Riccardo Fodde. (1997) Molecular analysis of theAPC gene in 105 Dutch kindreds with familial adenomatous polyposis: 67 germline mutations identified by DGGE, PTT, and southern analysis. Human Mutation 9:1, 7-16
    CrossRef

  162. 162

    John M. Carethers. (1996) THE CELLULAR AND MOLECULAR PATHOGENESIS OF COLORECTAL CANCER. Gastroenterology Clinics of North America 25:4, 737-754
    CrossRef

  163. 163

    Koyamangalath Krishnan, Dean E. Brenner. (1996) CHEMOPREVENTION OF COLORECTAL CANCER. Gastroenterology Clinics of North America 25:4, 821-858
    CrossRef

  164. 164

    Randall W. Burt. (1996) FAMILIAL RISK AND COLORECTAL CANCER. Gastroenterology Clinics of North America 25:4, 793-803
    CrossRef

  165. 165

    Alberto Achille, Maria T. Scupoli, Alba R. Magalini, Giuseppe Zamboni, Maria G. Romanelli, Simonetta Orlandini, Maria O. Biasi, Nicholas R. Lemoine, Roberto S. Accolla, Aldo Scarpa. (1996) APC gene mutations and allelic losses in sporadic ampullary tumours: Evidence of genetic difference from tumours associated with familial adenomatous polyposis. International Journal of Cancer 68:3, 305-312
    CrossRef

  166. 166

    Steven H. Itzkowitz, Bruce Greenwald, Stephen J. Meltzer. (1996) Colon carcinogenesis in inflammatory bowel disease. Inflammatory Bowel Diseases 1:2, 142-158
    CrossRef

  167. 167

    Kenneth W Kinzler, Bert Vogelstein. (1996) Lessons from Hereditary Colorectal Cancer. Cell 87:2, 159-170
    CrossRef

  168. 168

    N. S. Thakker, D. G. R. Evans, K. Homer, D. R. Davies, J. Armstrong, S. Guy, R. Harris, P. Sloan. (1996) Florid oral manifestations in an atypical familial adenomatous polyposis family with late presentation of colorectal polyps. Journal of Oral Pathology and Medicine 25:8, 459-462
    CrossRef

  169. 169

    Sam Thiagalingam, Christoph Lengauer, Frederick S. Leach, Mieke Schutte, Stephan A. Hahn, Joan Overhauser, James K.V. Willson, Sanford Markowitz, Stanley R. Hamilton, Scott E. Kern, Kenneth W. Kinzler, Bert Vogelstein. (1996) Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nature Genetics 13:3, 343-346
    CrossRef

  170. 170

    Gregory J. Riggins, Sam Thiagalingam, Ester Rozenblum, Craig L. Weinstein, Scott E. Kern, Stanley R. Hamilton, James K.V. Willson, Sanford D. Markowitz, Kenneth W. Kinzler, Bert Vogelstein. (1996) Mad-related genes in the human. Nature Genetics 13:3, 347-349
    CrossRef

  171. 171

    Karl-Friedrich Becker, Ulrike Reich, Gabriele Handschuh, Claudia Dalke, Heinz Höfler. (1996) Non-radioactive protein truncation test (nrPTT) for rapid detection of gene mutations. Trends in Genetics 12:7, 250
    CrossRef

  172. 172

    Diane M. Radford, Barbara A. Zehnbauer. (1996) INHERITED BREAST CANCER. Surgical Clinics of North America 76:2, 205-220
    CrossRef

  173. 173

    Paolo Gasparini, Leonardo D'Agruma, Gian Pio Cillis, Paolo Balestrazzi, Rita Mingarelli, Leopoldo Zelante. (1996) Scanning the first part of the neurofibromatosis type 1 gene by RNA-SSCP: Identification of three novel mutations and of two new polymorphisms. Human Genetics 97:4, 492-495
    CrossRef

  174. 174

    Shi-Long Lu, Yoshimitsu Akiyama, Hiromi Nagasaki, Tadashi Nomizu, Eiichi Ikeda, Shozo Baba, Kyosuke Ushio, Takeo Iwama, Kazuo Maruyama, Yasuhito Yuasa. (1996) Loss or Somatic Mutations of hMSH2 Occur in Hereditary Nonpolyposis Colorectal Cancers with hMSH2 Germline Mutations. Cancer Science 87:3, 279-287
    CrossRef

  175. 175

    C. Cunningham, M. G. Dunlop. (1996) Molecular genetic basis of colorectal cancer susceptibility. British Journal of Surgery 83:3, 321-329
    CrossRef

  176. 176

    Michael C. Luce, Cameron G. Binnie, Matthew C. Cayouette, Lauren N. W. Kam-Morgan. (1996) Identification of DNA mismatch repair gene mutations in hereditary nonpolyposis colon cancer patients. International Journal of Cancer 69:1, 50-52
    CrossRef

  177. 177

    Marion Mandl, Reiner Caspari, Anna Jauch, Thorsten Böker, Heidrun Raschke, Marlies Sengteller, Peter Propping, Waltraut Friedl. (1996) Familial adenomatous polyposis: A submicroscopic deletion at the APC locus in a family with mentally normal patients. Human Genetics 97:2, 204-208
    CrossRef

  178. 178

    Bo Liu, Ramon Parsons, Nickolas Papadopoulos, Nicholas C. Nicolaides, Henry T. Lynch, Patrice Watson, Jeremy R. Jass, Malcolm Dunlop, Andrew Wyllie, Païvi Peltomäki, Albert De La Chapeele, Stanley R. Hamilton, Bert Vocelstein, Kenneth W. Kinzler. (1996) Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients. Nature Medicine 2:2, 169-174
    CrossRef

  179. 179

    FitzGerald, Michael G., MacDonald, Deborah J., Krainer, Michael, Hoover, Ingrid, O'Neil, Erin, Unsal, Hilal, Silva-Arrieto, Sandra, Finkelstein, Dianne M., Beer-Romero, Peggy, Englert, Christoph, Sgroi, Dennis C., Smith, Barbara L., Younger, Jerry W., Garber, Judy E., Duda, Rosemary B., Mayzel, Kathleen A., Isselbacher, Kurt J., Friend, Stephen H., Haber, Daniel A., . (1996) Germ-Line BRCA1 Mutations in Jewish and Non-Jewish Women with Early-Onset Breast Cancer. New England Journal of Medicine 334:3, 143-149
    Full Text

  180. 180

    Elias I. Traboulsi, John Apostolides, Francis M. Giardiello, Anne J. Krush, Susan V. Booker, Stanley R. Hamilto, Irene E. Maumenee Hussels. (1996) Pigmented ocular fundus lesions and APC mutations in familial adenomatous polyposis. Ophthalmic Genetics 17:4, 167-174
    CrossRef

  181. 181

    Randall W. Burt. (1996) Cohorts with familial disposition for colon cancers in chemoprevention trials. Journal of Cellular Biochemistry 63:S25, 131-135
    CrossRef

  182. 182

    Eric R. Fearon. (1996) Colorectal cancer: Molecular genetic studies and their future clinical applications. Medical and Pediatric Oncology 27:S1, 35-40
    CrossRef

  183. 183

    Juan R. Sanabria, Ruth Croxford, Theresa C. Berk, Zane Cohen, Bharati V. Bapat, Steven Gallinger. (1996) Familial segregation in the occurrence and severity of periampullary neoplasms in familial adenomatous polyposis. The American Journal of Surgery 171:1, 136-141
    CrossRef

  184. 184

    Hartley S. Stem. (1996) Contributions of molecular genetics to the clinical management of colorectal cancer. The American Journal of Surgery 171:1, 10-15
    CrossRef

  185. 185

    Henry T. Lynch, Thomas Smyrk, Thomas McGinn, Stephen Lanspa, Jennifer Cavalieri, Jane Lynch, Susan Slominski-Castor, Matthew C. Cayouette, Ira Priluck, Michael C. Luce. (1995) Attenuated familial adenomatous polyposis (AFAP) a phenotypically and genotypically distinctive variant of FAP. Cancer 76:12, 2427-2433
    CrossRef

  186. 186

    Zora Sulekova, Julio Reina-Sanchez, Wolfgang G. Ballhausen. (1995) Multiple APC messenger RNA isoforms encoding exon 15 short open reading frames are expressed in the context of a novel exon 10A-derived sequence. International Journal of Cancer 63:3, 435-441
    CrossRef

  187. 187

    Daniel C. Chung, Anil K. Rustgi. (1995) DNA mismatch repair and cancer. Gastroenterology 109:5, 1685-1699
    CrossRef

  188. 188

    Christopher J.N. Rall, Jaime A. Rivera, Barbara A. Centeno, Carlos Fernandez-del Castillo, David W. Rattner, Andrew L. Warshaw, Anil K. Rustgi. (1995) Peritoneal exfoliative cytology and Ki-ras mutational analysis in patients with pancreatic adenocarcinoma. Cancer Letters 97:2, 203-211
    CrossRef

  189. 189

    Samuel Broder, Judith E. Karp. (1995) Progress against cancer. Journal of Cancer Research and Clinical Oncology 121:11, 633-647
    CrossRef

  190. 190

    Michael C. Luce, Giancarlo Marra, Dharam P. Chauhan, Luigi Laghi, John M. Carethers, Sajeev P. Cherian, Mary Hawn, Cameron G. Binnie, Lauren N.W. Kam-Morgan, Matthew C. Cayouette, Minoru Koi, C.Richard Boland. (1995) In vitro transcription/translation assay for the screening of hMLH1 and hMSH2 mutations in familial colon cancer. Gastroenterology 109:4, 1368-1374
    CrossRef

  191. 191

    Zora Šuleková, Wolfgang G. Ballhausen. (1995) A novel coding exon of the human adenomatous polyposis coli gene. Human Genetics 96:4, 469-471
    CrossRef

  192. 192

    ERIC R. FEARON. (1995) Molecular Genetics of Colorectal Cancer. Annals of the New York Academy of Sciences 768:1, 101-110
    CrossRef

  193. 193

    Nickolas Papadopoulos, Fredrick S. Leach, Kenneth W. Kinzler, Bert Vogelstein. (1995) Monoallelic mutation analysis (MAMA) for identifying germline mutations. Nature Genetics 11:1, 99-102
    CrossRef

  194. 194

    M MACCOLLIN. (1995) CNS young investigator award lecture: Molecular analysis of the neurofibromatosis 2 tumor suppressor. Brain and Development 17:4, 231-238
    CrossRef

  195. 195

    Frans B.L. Hogervorst, Renée S. Cornelis, Mattie Bout, Margreethe van Vliet, Jan C. Oosterwijk, Renske Olmer, Bert Bakker, Jan G.M. Klijn, Hans F.A. Vasen, Hanna Meijers-Heijboer, Fred H. Menko, Cees J. Cornelisse, Johan T. den Dunnen, Peter Devilee, Gert-Jan B. van Ommen. (1995) Rapid detection of BRCA1 mutations by the protein truncation test. Nature Genetics 10:2, 208-212
    CrossRef

  196. 196

    Sylviane Olschwang, Pierre Laurent-Puig, Thomas Melot, Bénédicte Thuille, Gilles Thomas. (1995) High resolution genetic map of the adenomatous polyposis coli gene (APC) region. American Journal of Medical Genetics 56:4, 413-419
    CrossRef

  197. 197

    Judith E. Karp, Samuel Broder. (1995) Molecular foundations of cancer: New targets for intervention. Nature Medicine 1:4, 309-320
    CrossRef

  198. 198

    Michiko Miyaki, Kiyoko Tanaka, Rei Kikuchi-Yanoshita, Masatoshi Muraoka, Motoko Konishi. (1995) Familial polyposis: recent advances. Critical Reviews in Oncology/Hematology 19:1, 1-31
    CrossRef

  199. 199

    Bo Liu, Susan M. Farrington, Gloria M. Petersen, Stanley R. Hamilton, Ramon Parsons, Nickolas Papadopoulos, Takato Fujiwara, Jin Jen, Kenneth W. Ainzler, Andrew H. Wyllie, Bert Vogelstein, Malcolm G. Dunlop. (1995) Genetic instability occurs in the majority of young patients with colorectal cancer. Nature Medicine 1:4, 348-352
    CrossRef

  200. 200

    Hamilton, Stanley R., Liu, Bo, Parsons, Ramon E., Papadopoulos, Nickolas, Jen, Jin, Powell, Steven M., Krush, Anne J., Berk, Theresa, Cohen, Zane, Tetu, Bernard, Burger, Peter C., Wood, Patricia A., Taqi, Fowzia, Booker, Susan V., Petersen, Gloria M., Offerhaus, G. Johan A., Tersmette, Anne C., Giardiello, Francis M., Vogelstein, Bert, Kinzler, Kenneth W., . (1995) The Molecular Basis of Turcot's Syndrome. New England Journal of Medicine 332:13, 839-847
    Full Text

  201. 201

    Toribara, Neil W., Sleisenger, Marvin H., . (1995) Screening for Colorectal Cancer. New England Journal of Medicine 332:13, 861-867
    Full Text

  202. 202

    Randall W. Burt, M.D, James A. DiSario, M.D, Lisa Cannon-Albright, Ph.D. (1995) GENETICS OF COLON CANCER: Impact of Inheritance on Colon Cancer Risk 1. Annual Review of Medicine 46:1, 371-379
    CrossRef

  203. 203

    Mark S. Redston, Nickolas Papadopoulos, Carlos Caldas, Kenneth W. Kinzler, Scott E. Kern. (1995) Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias. Gastroenterology 108:2, 383-392
    CrossRef

  204. 204

    Bo Liu, Nicholas C. Nicolaides, Sanford Markowitz, James K.V. Willson, Ramon E. Parsons, Jin Jen, Nickolas Papadopolous, Päivi Peltomäki, Albert de la Chapelle, Stanley R. Hamilton, Kenneth W. Kinzler, Bert Vogelstein. (1995) Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nature Genetics 9:1, 48-55
    CrossRef

  205. 205

    Alessandro Cama, Raffaele Palmirotta, Maria Cristina Curia, Diana L. Esposito, Annalisa Ranieri, Ferdinando Ficari, Rosa Valanzano, Pasquale Battista, Andrea Modesti, Francesco Tonelli, Renato Mariani-Costantini. (1995) Multiplex PCR analysis and genotype-phenotype correlations of frequentAPC mutations. Human Mutation 5:2, 144-152
    CrossRef

  206. 206

    Rustgi, Anil K.. (1994) Hereditary Gastrointestinal Polyposis and Nonpolyposis Syndromes. New England Journal of Medicine 331:25, 1694-1702
    Full Text

  207. 207

    Frank K Fujimura. (1994) Diagnosis and the new genetics. Current Opinion in Biotechnology 5:6, 654-662
    CrossRef

  208. 208

    Ruth A. Heim, Lawrence M. Silverman, Rosann A. Farber, Lauren N.W. Kam-Morgan, Michael C. Luce. (1994) Screening for truncated NF1 proteins. Nature Genetics 8:3, 218-219
    CrossRef

  209. 209

    Richard L. Nelson. (1994) Diet and adenomatous polyp risk. Seminars in Surgical Oncology 10:3, 165-175
    CrossRef

  210. 210

    Liu, Edison T., . (1993) From the Molecule to Public Health. New England Journal of Medicine 329:27, 2028-2029
    Full Text